Taisho believes that it must develop products that are effective, safe and highly convenient, before it can build brands by winning the trust of consumers. The R&D program of the self-medication operation group is aimed at fulfilling these three conditions as part of Taisho's ongoing search for products that benefit consumers' daily lives.
Efficacy and safety are both reflected in switch Rx-to-OTC drugs, which incorporate the active ingredients in prescription drugs into over-the-counter medicines, and direct OTC drugs, which receive immediate over-the-counter approval. The result of our R&D activity takes shape as the products we provide to consumers.
Convenience, after ensuring efficacy and safety, expresses the search for a form best suited to the attributes and preferences of varied users. Taisho continues to introduce new products into its existing series that add convenience to consumer's live, such as the Pabron Stick Jelly, a cough suppressant in gelatin form that can be taken without water, and Colac Suppository-Type, a laxative that works in 10 to 30 minutes.